how to take semaglutide Use Ozempic® Pen How to Inject Semaglutide for

PlexusDx supports this precision-wellness model by offering both compounded GLP-1 options and genetic insights to inform conversations with your healthcare provider

BMI and Comorbidity Criteria FDA labeling for semaglutide 2.4 mg (Wegovy) specifies a starting BMI of 30 or greater, or 27 or greater in the presence of at least one weight-related condition

Lawsuits describe patients suffering from persistent gastrointestinal symptoms, including severe nausea, vomiting, and impaired stomach emptying

The "highest tolerated dose" philosophy that dominates much of GLP-1 prescribing does not always produce the best outcomes

1-MNA quantification as target-engagement biomarker

When to Contact Your Healthcare Provider While mild to moderate fatigue is common, it should not be debilitating